Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.
The company today priced its public offering of 4,054,055 shares at $18.50 per share.
Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.
RAPT has traded in the range of $9.85- $40.74 in the last 1 year.
Source: Read Full Article
Lates News:
-
Bank Of Japan's Dovish Stance Offsets Waning Euphoria Of Fed Rate Cut
-
Amidst Hawkish Fed Hints, Markets Wary Of Jobs Data
-
Markets Rise As Inflation Worries Ease
-
A10 Networks Sinks On Q3 Revenue Outlook Below Street View
-
Bitcoin Shrimps and Crabs Accumulate BTC Aggressively Amid Heightened Institutional Interest